Usana Health Sciences (USNA) Liabilities and Shareholders Equity (2016 - 2026)
Usana Health Sciences has reported Liabilities and Shareholders Equity over the past 16 years, most recently at $739.0 million for Q2 2026.
- Quarterly Liabilities and Shareholders Equity fell 1.02% to $739.0 million in Q2 2026 from the year-ago period, while the trailing twelve-month figure was $2.9 billion through Apr 2026, up 5.2% year-over-year, with the annual reading at $742.9 million for FY2026, 0.71% down from the prior year.
- Liabilities and Shareholders Equity was $739.0 million for Q2 2026 at Usana Health Sciences, down from $742.9 million in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $748.2 million in Q4 2024 and troughed at $556.1 million in Q4 2022.
- The 5-year median for Liabilities and Shareholders Equity is $630.3 million (2024), against an average of $648.5 million.
- Year-over-year, Liabilities and Shareholders Equity dropped 9.85% in 2022 and then grew 18.64% in 2025.
- A 5-year view of Liabilities and Shareholders Equity shows it stood at $596.5 million in 2022, then grew by 6.07% to $632.8 million in 2023, then rose by 18.24% to $748.2 million in 2024, then fell by 2.89% to $726.6 million in 2025, then increased by 1.7% to $739.0 million in 2026.
- Per Business Quant, the three most recent readings for USNA's Liabilities and Shareholders Equity are $739.0 million (Q2 2026), $742.9 million (Q1 2026), and $726.6 million (Q3 2025).